Hosted by Wellcome
This webinar will provide further information for Wellcome's new funding scheme on cognitive and functional outcomes in psychosis, see the funder's website for details on the scheme.
Wellcome will consider two types of applications to this call:
Intervention development and evaluation (up to 5 years, up to £3 million)
- Applications to develop and evaluate interventions that are applied early in the disease course.
- Applications must build on proof-of-concept data and can be anywhere on the translational pipeline up to and including efficacy testing.
- Interventions of any type (or a combination of interventions) will be considered.
- Evaluations can include but are not limited to: randomised designs, cluster designs, innovative designs such as adaptive or factorial trials, natural experiments and modelling (for example, simulation studies).
Research on markers of cognitive functioning (up to 3 years, up to £1 million)
- Applications to advance prediction of risk or treatment response in people experiencing, or at risk of, psychosis using markers of cognitive functioning.
- Primary (for example, observational or experimental work) or secondary research (for example, data analysis) are both in scope.
- Research could be standalone or add on to already funded/ongoing research (for example, to existing cohorts or clinical trials).
If you are based at UoB, please let Zoe Holland (zoe.holland@bristol.ac.uk) know if you intend to apply, and involve the finance team early on in your application.
Applicants will need to ensure that their Head of School is supportive of them pursuing an application, noting that there is a large and unfunded time commitment for the lead applicant (20%) and any co-applicants (10%), and that Wellcome is a charity and does not fund overheads. In addition, if you will be requesting specialised equipment that costs £100,000 or more, Wellcome expect a contribution of at least 25% from the host organisation or another source.